Luoxin Pharmaceuticals Group Stock (002793.SZ): Cefozopran sodium for injection passes generic consistency evaluation.

Luoxin Pharmaceuticals Group Stock (002793.SZ) has released an announcement, announcing that its subsidiary Shandong Luoxin Pharmaceuticals Group Co., Ltd...

Zhitong FinanceAug 1 04:29 ET

Luoxin Pharmaceuticals Unit's Montmorillonite Powder Passes Chinese Drug Regulator's Consistency Evaluation

MT NewswiresJul 24 23:58 ET

Luoxin Pharmaceuticals Group Stock (002793.SZ): Montmorillonite Powder has passed the consistency evaluation of generic drugs.

Luoxin Pharmaceuticals Group Stock (002793.SZ) announced that its subsidiary, Shandong Luoxin Lekang Pharmaceutical Co., Ltd. ("Luoxin...")

Zhitong FinanceJul 24 08:20 ET

Luoxin Pharmaceuticals Group Stock (002793.SZ): Luoxin Anruowei passed the on-site inspection by the US FDA.

Luoxin Pharmaceuticals Group Stock (002793.SZ) announced on July 17 that its subsidiary, Luoxin Anruovita Pharmaceutical Co., Ltd. (Chengdu) (hereinafter referred to as "Luoxin Anruovita") indirectly received a current good manufacturing practice (CGMP) inspection by the US Food and Drug Administration (FDA) on August 3, 2023. Recently, Luoxin Anruovita received an Establishment Inspection Report (EIR) issued by the US FDA, confirming this inspection.

Gelonghui FinanceJul 17 06:15 ET

Luoxin Pharmaceuticals Group Stock: 2024 Interim Performance Forecast

Sensex a shareJul 9 12:00 ET · Announcements

Luoxin Pharmaceuticals to Trial Acid Blocker Drug; Shares Jump 6%

MT NewswiresJul 1 02:57 ET